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ABSTRACT
Objective: In the present work, a variety of new heterocyclic compounds namely aza-β- lactam, cyclicimides, 1,3-thiazole, and 1,2,4-triazole was prepared.
Methods: Procedure includes the synthesis of aza-β- lactam, cyclic imides, 1,3-thiazole, and 1,2,4-triazole. The synthesis was carried out in eleven 
steps using N-(Ñ-substituted phenylglycyl) saccharin derivatives (1a,b) as a starting material and converted to benzoic acid derivatives (2a,b) and 
then to ester derivatives (3a,b), which finally convers to benzohydrazide derivatives (4a,b). The cyclization of (4a,b) with carbon disulfide and 
hydrazine hydrate (80%) in the presence of potassium hydroxide gives 1,2,4-triazole compounds (5a,b), and subsequently (5a,b) derivatives reacted 
with different aromatic aldehydes in the presence of few drops of glacial acetic acid to give Schiff bases (6a-f). Compounds (7a-b) was prepared by 
the reaction of compounds (4a,b) with chloroacetyl chloride. 1,3-thiazole derivatives (8a,b) were synthesized through the cyclization of compounds 
(7a,b) with thiourea. Schiff bases (9a-f) were obtained by condensation of (4a,b) with different aromatic aldehydes in the presence of few drops of 
glacial acetic acid. Aza-β-lactam compounds (10a-f) were prepared by the cycloaddition of Schiff-bases (9a-f) with phenyl isocyanate through [2+2] 
cycloaddition reaction. Reaction (4a,b) with various acid anhydrides in presence of acetic acid gave the corresponding cyclic imide (11a-f). 
Results: The results showed that compounds (5a) and (10e) have a good activity against Gram-positive bacterium and no activity against Gram-
negative bacterium, compared to standard drugs (ciprofloxacin and amoxicillin), while compounds (8a) and (6b) have a high activity against fungi, 
compared to standard drugs (metronidazole benzoate), and the other tested compounds have low-to-moderate activity.
Conclusion: 1,2,4-triazole is a most potent assemblage of Gram-positive bacterium retardants and cyclic imides are a most potent assemblage of fungi 
retardants.
Keywords: 1,2,4-Triazole, Aza-β-lactam, Cyclic imide, Antibacterial, Antifungal.
INTRODUCTION
The heterocyclic compounds are enjoying their importance as being the 
center of activity. The nitrogen-containing heterocyclic compounds were 
found in abundance in most of the medicinal compounds and the presence 
of three nitrogen heteroatoms in five-membered ring systems defines 
an interesting class of compounds [1]. The first Schiff base compounds 
were reported by Hugo Schiff in 1864. In recent years, the chemistry of 
Schiff bases contains N-donor atom which has been extensively studied 
and has acquired a great interest because of the azomethine C=N linkage 
essential for biological activity [2]. 1,2,4-triazoles constitute broad 
realization due to their useful application in different areas of biological 
activity, and as industrial intermediates, it is effectively used in polymers, 
dyestuff, photographic chemicals, and agricultural chemicals [3]. There 
is some biological activity of 1,2,4-triazole such as antimicrobial [4], 
anti-inflammatory [5], and antioxidant [6]. The β-lactam core is the 
fundament building block of an exceptionally large class of antibiotics 
that all share a common mode of action but have quite distinct properties 
in terms of spectrum pharmacokinetics and, to some extent, activity 
against resistant strains [7]. Cyclic imides have an important in the 
creation of novel medical materials, most widely method to synthesize 
cyclic imides by heating dicarboxylic acids or anhydrides with an amine 
and harsh thermal reaction conditions, and activation reagents are 
mandatory [8,9]. Thiazole and its derivatives comprise an important 
class of heterocyclic compounds with high biological activity such as 
antimicrobial, antipyretic, antiparasitic, antihistaminic, and antiviral 
activities [10].
METHODS
All chemicals were purchased from Fluka, BDH, and Merk. Melting 
points were recorded using electrothermal melting point apparatus. 
Fourier-transform infrared (FTIR) spectral data were recorded on 
a Shimadzu FTIR-8400 S spectrophotometer in the Department of 
Chemistry, College of Science, University of Baghdad. Nuclear magnetic 
resonance (1H-NMR) spectrum was recorded in the Central Laboratory 
of Isfahan University and Sharif University of Technology, 400 MHz, 
using deuterated dimethyl sulfoxide (DMSO) as a solvent.
Step 1: Synthesis of N-(Ñ-substituted phenylglycyl) saccharin 
derivatives (1a,b) [11]
A mixture of N-(2-chloroacetyl) saccharin (0.01 mole, 2.6 g), appropriate 
aromatic amine, namely p-toluidine and o-toluidine (0.01 mole), in 
15 mL chloroform was refluxed for 6 h. The formed precipitate was 
filtered, washed with water, dried, and finally recrystallized from 
chloroform to give compounds (1a,b) respectively.
N-[Ñ-(p-toluylglycyl)] saccharin (1a)
M.p=220–223°C, yield=92%, Rf=0.673, IR (KBr) cm−1: 3093 (N-H), 2975 
(C-H alph), 1722 (C=O), 1296 (C-N amine).
N-[Ñ-(o-toluylglycyl)] saccharin (1b)
M.p=218–221°C, yield=86%, Rf=0.630, IR (KBr) cm−1:3091 (N-H), 2972 
(C-H alph), 1722 (C=O), 1296 (C-N amine).
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Step 2: Synthesis of benzoic acid derivatives (2a,b) [12]
A mixture of compounds (1a,b) (0.01 mole) and 10% NaOH (20 mL) was 
heated in a steam bath for 30 min, then cooled it at room temperature, 
and neutralized by hydrochloric acid (HCl), and the white precipitate 
appearing was filtered and then recrystallized from absolute ethanol, to 
give compounds (2a,b) respectively.
O-[N-(p-toluylglycyl) sulfamoyl] benzoic acid (2a)
M.p=140–143°C, yield=94%, Rf=0.599, IR (KBr) cm−1: 3352 (OH), 3252 
(N-H), 3041 (C-H Ar), 2912 (C-H alpha), 1710 (C=O), 1587 (C=C Ar), 
1542 (C=O amide I), 1249 (C-O acid).
o-[N-(o-toluylglycyl) sulfamoyl] benzoic acid (2b)
M.p=138–139°C, yield=84%, Rf=0.512, IR (KBr) cm−1: 3351 (OH), 3252 
(N-H), 3041 (C-H Ar), 2912 (C-H alpha), 1710 (C=O), 1587 (C=C Ar), 
1542 (C=Oamide I), 1249 (C-O acid). 1H-NMR and 13C-NMR spectra δ 
(ppm): 1.5 (s, 3H, Ar-CH3), 3.3 (s, 2H, O=C-CH2-NH), 7.1–8.2 (m, 9H, 
Ar-H, NHSO2), 13.7 (s, 1H, COOH). The 13C-NMR spectra 40 (Ar-CH3), 
130–140 (Ar), 142 (C=O) amide, 168 (C=O) acid.
Step 3: Synthesis of ester derivatives (3a,b) [13]
Mixture of compounds (2a,b) (0.001 mole) and (30 mL) absolute 
ethanol, in the presence of concentrated sulfuric acid (0.5 mL), 
was refluxed for 8 h, and after cooling and naturalized by sodium 
bicarbonate, the white precipitate was appeared and crystallized from 
absolute ethanol, to give compounds (3a,b), respectively.
Ethyl-o-[N-(p-toluylglycyl) sulfamoyl] benzoate (3a)
M.p=278–279°C, yield=89%, Rf=0.564, IR (KBr) cm−1: 3238 (N-H), 3040 
(C-H Ar), 2918 (C-H alpha), 1716 (C=O ester), 1618 (C=Oamide I), 1066 
(C-O ester).
Ethyl-o-[N-(o-toluylglycyl) sulfamoyl] benzoate (3b)
M.p=274–276°C, yield=77%, Rf=0.533, IR (KBr) cm−1: 3249 (N-H), 3022 
(C-H Ar), 2908 (C-H alpha), 1726 (C=O ester), 1620 (C=Oamide I), 1068 
(C-O ester). While 1H-NMR and 13C-NMR spectra δ (ppm):1.5 (s, 3H, Ar-
CH3), 3.2 (q, 2H, O-CH2), 3.6 (s, 2H, O=C-CH2-NH), 7.1–8.2 (m, 9H, Ar-H, 
NHSO2), and 13C-NMR 30 (CH2-CH3), 40 (CH3-Ar), 134–126 (C-Ar), 174 
(C=O) ester.
Step 4: Synthesis of benzohydrazide derivatives (4a,b) [14]
To the solution of compounds (3a,b) (0.001 mole) in absolute ethanol 
(15 mL), hydrazine hydrate (0.001 mole) was added, and the mixture 
was refluxed for 4 h; after cooling, the formed white precipitate was 
filtered and recrystallized by absolute ethanol, to give compounds 
(4a,b), respectively.
O-[N-(p-toluylglycyl) sulfamoyl] benzohydrazide (4a)
M.p=320–322°C, yield=83%, Rf=0.601, IR (KBr) cm−1: 3402–3305 
(NH-NH2), 3055 (C-H Ar), 2962 (C-H alpha), 1631 (C=O amide I), 1587 
(C=Oamide II), 1498 (C=C Ar).
O-[N-(o-toluylglycyl) sulfamoyl] benzohydrazide (4b)
M.p=316–317°C, yield=76%, Rf=0.455, IR (KBr) cm−1: 3402–3305 (NH-
NH2), 3076 (C-H Ar), 2900 (C-H alpha), 1701 (C=O Amide I), 1542 (C=O 
amide II), 1487 (C=C Ar).
Step 5: Synthesis of 1,2,4-triazole derivatives (5a,b) [15]
A mixture of compounds (4a,b) (0.001 mole), potassium hydroxide 
(0.01 mole, 0.8 g) and carbon disulfide (0.1 mole) in absolute ethanol, 
was refluxed for 4 h in water bath, then excess carbon disulfide was 
removed, after that, added (0.01 mole, 0.5 g) hydrazine hydrate 80%, 
and refluxed for 3 h, after cooling, acidification with 20% HCl, and 
appearance precipitate was filtered and recrystallized from ethanol to 
give triazole derivatives (5a,b), respectively.
3-[o-(N-p-toluylglycyl)sulfamoyl]-4-amino-5-mercapto-1,2,4-
triazole (5a)
M.p=152–154°C, yield =91%, Rf=0.576, IR (KBr) cm−1: 3213, 3267 (NH-
NH2), 3087 (C-H Ar), 2929 (C-H alpha), 2661 (SH), 1645 (C=Oamide I), 
1596 (C=N), 1502 (C=C Ar). The 1H-NMR spectrum δ (ppm): 1.6 (s, 3H, 
Ar-CH3), 3.6 (s, 2H, NH2), 4.2 (s, 2H, CH2-C=O), 5.2 (s, 1H, CH-triazole 
ring), 7.1–8.1 (m, 9H, Ar-H, NHSO2), 12.7 (s, 1H, SH).
3-[o-(N-o-toluylglycyl)sulfamoyl]-4-amino-5-mercapto-1,2,4-
triazole (5b)
M.p=144–146°C, yield=86%, Rf=0.539, IR (KBr) cm−1: 3213, 3267 (NH-
NH2), 3087 (C-H Ar), 2929 (C-H alpha), 2661 (SH), 1643 (C=Oamide I), 
1596 (C=N), 1502 (C=C Ar).
Step 6: Synthesis of Schiff bases (6a-f) derived from compounds 
(5a,b) [16]
A mixture of compounds (5a,b) (0.001 mole), appropriate aromatic aldehyde, 
namely 4,4-dimethylaminobenzaldehyde, 4-methoxybenzaldehyde, and 
2,4-dimethoxybenzaldehyde, and a few drops of glacial acetic acid in 10 mL 
absolute ethanol, was refluxed for 5 h. The formed precipitate after cooling 
was filtered, dried, and recrystallized from ethanol to give compounds (6a-f).
3-[o-(N-p-toluylglycyl)sulfamoyl]-4-(4,4-dimethylaminobenz 
ylidine)-5-mercapto-1,2,4-triazole (6a)
M.p=177–175°C, yield=90%, Rf=0.423, IR (KBr) cm−1: 3253 (NH), 3023 
(C-H Ar), 2918 (C-H alpha), 1602 (C=N imine), 1525(C=N).
3-[o-(N-p-toluylglycyl)sulfamoyl]-4-(4-methoxybenzylidine)-5-
mercapto-1,2,4-triazole (6b)
M.p=185–183°C, yield=87%, Rf=0.451, IR (KBr) cm−1: 3256 (NH), 3022 
(C-H Ar), 2935 (C-H alpha), 1602 (C=N imine), 1537 (C=N).
3-[o-(N-p-toluylglycyl)sulfamoyl]-4-(2,4-dimethoxybenzylidine)-
5-mercapto-1,2,4-triazole (6c)
M.p=166–165°C, yield=81%, Rf=0.498, IR (KBr) cm−1: 3218 (NH), 3006 
(C-H Ar), 2925(C-H alpha), 1604 (C=N imine), 1573(C=N).
3-[o-(N-o-toluylglycyl)sulfamoyl]-4-(4,4-dimethylaminobenz 
ylidine)-5-mercapto-1,2,4-triazole (6d)
M.p=173–171°C, Yield=86%, Rf=0.383, IR (KBr) cm−1: 3200 (NH), 3023 
(C-H Ar), 2920 (C-H alpha), 1604 (C=N imine), 1523 (C=N).
3-[o-(N-o-toluylglycyl)sulfamoyl]-4-(4-methoxybenzylidine)-5-
mercapto-1,2,4-triazole (6e)
M.p=179–178°C, yield=81%, Rf=0.376, IR (KBr) cm−1: 3255(NH), 
3020(C-H Ar), 2923 (C-H alpha), 1614 (C=N imine), 1589 (C=N).
3-[o-(N-o-toluylglycyl)sulfamoyl]-4-(2,4-dimethoxybenzylidine)-
5-mercapto-1,2,4-triazole (6f)
M.p=156–153°C, yield =82%, Rf=0.364, IR (KBr) cm−1: 3200 (NH), 3001 
(C-H Ar), 2920 (C-H alpha), 1612 (C=N imine), 1502 (C=N).
Step 7: Synthesis of N-chloroacetyl benzohydrazide derivatives 
(7a,b) [17]
A mixture of compounds (4a,b) (0.001 mole) dissolved in 10 mL of dry 
benzene was stirred in ice bath for 30 min, then chloroacetyl chloride 
was added by dropwise then stirring at room temperature for 1/2 h, and 
the produced white precipitate was filtrated and recrystallized from 
benzene and methanol (3:2) to give compounds (7a,b) respectively.
O-[N-(p-toluylglycyl)sulfamoyl]-Ñ-(chloroacetyl) benzohydrazide 
(7a)
M.p=147–145°C, yield =90%, Rf=0.341, IR (KBr) cm−1: 3184 (NH), 3043 
(C-H Ar), 2958(C-H alpha), 1703, 1610 (C=O), 794 (C-Cl).
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O-[N-(o-toluylglycyl)sulfamoyl]-Ñ-(chloroacetyl)benzohydrazide 
(7b)
M.p=132–130°C, Yield =83%, Rf=0.387, IR (KBr) cm−1: 3182 (NH), 3043 
(C-H Ar), 2854 (C-H alpha), 1724, 1612 (C=O), 794 (C-Cl).
Step 8: Synthesis of 1,3-thiazole derivatives (8a,b)
A mixture of compound (7a,b) (0.001 mole) and 0.005 mole, 0.8 g, of 
thiourea, in 10 mL absolute ethanol, was refluxed for 4 h, and after 
cooling at room temperature, produced precipitate was filtered and 
recrystallized from ethanol to give compounds (8a,b) respectively.
O-[N-(p-toluylglycyl)sulfamoyl]-Ñ-(2-amino-1,3-thiazole-5-yl) 
benzohydrazide (8a)
M.p=192–194°C, yield =79%, Rf=0.749, IR (KBr) cm−1: 3390–3200 
(NH-NH2), 3060 (C-H Ar), 2800 (C-H alpha), 1714 (C=O amide I), 1514 
(C=C Ar), 1602 (C=N), 1514 (C=O amide II). The 1H-NMR spectrum of 
compound (8a) showed the following characteristic signals δ (ppm): 
1.6 (s, 3H, CH3-Ar), 3.3 (s, 2H, O=C-CH2-NH), 3.7) (s, 2H, NH2), 4.1 (s, 




M.p=186–185°C, yield =71%, Rf=0.518, IR (KBr) cm−1: 3390–3251 (NH-
NH2), 3047 (C-H Ar), 2962 (C-H alpha), 1710 (C=O amide I), 1429 (C=C 
Ar), 1606 (C=N), 1518(C=O amide II).
Step 9: Synthesis of Schiff bases (9a-f) derived from compounds 
(4a,b) [18]
The following Schiff-bases (9a-f) were prepared under similar 
conditions as for compounds (6a-f).
O-[N-(p-toluylglycyl)sulfamoyl]-Ñ-(4,4-dimethylaminobenz 
ylidine) benzamide (9a)
M.p=60–61°C, yield=88%, Rf=0.345, IR (KBr) cm−1: 3277 (NH), 3100 




M.p=79–81°C, yield=84%, Rf=0.467, IR (KBr) cm−1: 3246 (NH), 3040 




M.p=86–88°C, yield=89%, Rf=0.391, IR (KBr) cm−1: 3286 (NH), 3006 
(C-H Ar), 2975 (C-H alpha), 1604 (C=O amide I), 1579 (C=N), 1502 (C=O 
amide II). The 1H-NMR spectrum δ (ppm): 1.5 (s, 3H, Ar-CH3), 3.4 (s, 3H, 
OCH3), 3.8 (s, 2H, O=C-CH2-NH), 6.6 (s, 1H, CH=N), 7.1–7.9 (m, 9H, Ar-H, 
NHSO2), 8.8 (s, 1H, O=C-NH-N).
O-[N-(o-toluylglycyl)sulfamoyl]-Ñ-(4,4-dimethylaminobenz 
ylidine) benzamide (9d)
M.p=62–64°C, yield=83%, Rf=0.624, IR (KBr) cm−1: 3174 (NH), 3074 
(C-H Ar), 2979 (C-H alpha), 1639 (C=O amide I), 1602 (C=N), 1523 (C=O 
amide II). The 1H-NMR spectrum δ (ppm): 1.6 (s, 3H, Ar-CH3), 3.3 (s, 6H, 
(CH3)2N), 3.8 (s, 2H, O=C-CH2-NH), 6.7(s, 1H, CH=N), 7.1–7.9 (m, 9H, Ar-
H, NHSO2), 8.4 (s, 1H, O=C-NH-N).
O-[N-(o-toluyl glycyl) sulfamoyl]- Ñ-(4-methoxy benzylidine) 
benzamide (9e)
M.p=71–74°C, yield=82%, Rf=0.581, IR (KBr) cm−1: 3145 (NH), 3008 




M.p=90–92°C, yield=86%, Rf=0.468, IR (KBr) cm−1: 3290 (NH), 3008 
(C-H Ar), 2844 (C-H alpha), 1600 (C=O amide I), 1596 (C=N), 1502 (C=O 
amide II).
Step 10: Synthesis of Aza-β-lactam derivatives (10a-f) [19]
A mixture of Schiff bases (9a-f) (0.001 mole) and phenyl isocyanate 
(0.001 mole, 0.05 g) in chloroform (15 mL) was refluxed for 6 h. The 
solvent was removed and the residue was treated with a mixture of 1:1 
ethyl acetate and petroleum ether. The resultant precipitate was filtered 
and dried to give compounds (10a-f), respectively.
O-[N-(p-toluylglycyl)sulfamoyl]-N-[2-oxo-3-phenyl-4-(4,4-
dimethylamino phenyl-1,3-diazatidine-1-yl)] benzamide (10a)
M.p=102–104°C, yield=87%, Rf=0.321, IR (KBr) cm−1: 3307 (NH), 3060 
(C-H Ar), 2912 (C-H alpha), 1708 (C=O Aza-β-lactam), 1668 (C=O 
amide I), 1552 (C=O amide II).
O-[N-(p-toluylglycyl)sulfamoyl]-N-[2-oxo-3-phenyl-4-(4-methoxy 
phenyl-1,3-diazatidine-1-yl)] benzamide (10b)
M.p=114–115°C, yield=83%, Rf =0.433, IR (KBr) cm−1: 3400 (NH), 
3050 (C-H Ar), 2991 (C-H alpha), 1704 (C=O Aza-β-lactam), 1622(C=O 
amide I), 1560(C=O amide II).
O-[N-(p-toluylglycyl)sulfamoyl]-N-[2-oxo-3-phenyl-4-(2,4-
methoxyphenyl-1,3-diazatidine-1-yl)] benzamide (10c)
M.p=123–125°C, yield=80%, Rf=0.544, IR (KBr) cm−1: 3222 (NH), 3099 
(C-H Ar), 2921 (C-H alpha), 1701 (C=O Aza-β-lactam), 1672 (C=O 
amide I), 1541 (C=O amide II). The 1H-NMR spectrum δ (ppm): 1.2 (s, 
1H, NH-Ar), 1.6 (s, 3H, CH3-Ar), 3.6 (s, 3H, p-OCH3), 3.8 (s, 3H, o-OCH3), 
4.1 (s, 2H, O=C-CH2), 6.5 (s, 1H, N-CH-aza-β-lactam), 6.9–9.5 (m, 9H, 
Ar-H, NHSO2), 11.1 (s, 1H, N-NH-C=O).
O-[N-(o-toluylglycyl)sulfamoyl]-N-[2-oxo-3-phenyl-4-(4,4-
dimethylamino phenyl-1,3-diazatidine-1-yl)] benzamide (10d)
M.p=107–109°C, yield =80%, Rf=0.331, IR (KBr) cm−1: 3288 (NH), 
3061 (C-H Ar), 2979 (C-H alpha), 1710 (C=O Aza-β-lactam), 1672 (C=O 
amide I), 1552 (C=O amide II). The 1H-NMR spectrum δ (ppm): 1.2 (s, 
1H, NH-Ar), 1.6 (s, 3H, CH3-Ar), 3.4 (s, 6H, (CH3)2-N), 4.1 (s, 2H, O=C-




M.p=118–120°C, yield=77%, Rf=0.554, IR (KBr) cm−1: 3294 (NH), 3136 
(C-H Ar), 2900 (C-H alpha), 1708 (C=O Aza-β-lactam), 1647 (C=O 
amide I), 1556 (C=O amide II).
O-[N-(o-toluylglycyl)sulfamoyl]-N-[2-oxo-3-phenyl-4-(2,4-
methoxyphenyl-1,3-diazatidine-1-yl)] benzamide (10f)
M.p=129–132°C, yield=72.7%, Rf=0.342, IR (KBr) cm−1: 3290 (NH), 
3091 (C-H Ar), 2959 (C-H alpha), 1701 (C=O Aza-β-lactam), 1645 (C=O 
amide I), 1502(C=O amide II).
Step 11: Synthesis of cyclicimide derivatives (11a-f) [20]
A mixture of compounds (4a,b) (0.001 mole), appropriate acid 
anhydride, namely maleic anhydride, succinic anhydride, and phthalic 
anhydride (0.001 mole), in 15 mL acetic acid, was refluxed for 24 h. The 
formed precipitate was filtered, dried, and recrystallized from acetic 
acid to give compounds (11a-f), respectively.
11a-N-[o-[(Ñ-p-toluylglycyl) sulfamoyl] benzamedo succinimide: 
b.p=121°C, yield =60%, Rf=0.686, IR (KBr) cm−1: 3207 (NH), 3051 (C-H 
Ar), 2920 (C-H alpha), 1724 (C=O cyclic imide), 1765 (C=O amide I), 
1602 (C=C Ar), 1525 (C=O amide II).
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11b-N-[o-[(Ñ-p-toluylglycyl) sulfamoyl]benzamedomaleimide: m.p=227–
228°C, yield =79%, Rf=0.574, IR (KBr) cm−1: 3257 (NH), 3068 (C-H Ar), 
2900 (C-H alpha), 1797 (C=O cyclic imide), 1647 (C=O amide I), 1577 
(C=C Ar), 1552 (C=O amide II).
11c-N-[o-[(Ñ-p-toluylglycyl)sulfamoyl]benzamedophthalimide: 
m.p=236–238°C, yield =83%, Rf=0.666, IR (KBr) cm−1:3271 (NH), 
3011 (C-H Ar), 2810 (C-H alpha), 1747 (C=O cyclic imide), 1660 (C=O 
amide I), 1600 (C=C Ar), 1556 (C=O amide II). The 1H-NMR spectrum 
showed the following characteristic signals δ (ppm): Compound (11c): 
1.6 (s, 3H, Ar-CH3), 3.2 (s, 2H, Ar-NH-CH2), 7.4–8.2 (m, 13H, Ar-H, 
NHSO2), 11.5 (s, 1H, C=O-NH-N-).
11d-N-[o-[(Ñ-o-toluylglycyl)sulfamoyl] benzamedo succinimide: 
m.p=210–208°C, yield=76%, Rf=0.534, IR (KBr) cm−1: 3207 (NH), 
3011(C-H Ar), 2902 (C-H alpha), 1724 (C=O cyclic imide), 1600 (C=O 
amide I), 1577 (C=C Ar), 1561(C=O amide II).
11e-N-[o-[(Ñ-o-toluylglycyl)sulfamoyl] benzamedomaleimide: m.p=243–
245°C, yield=79%, Rf=0.681, IR (KBr) cm−1: 3255 (NH), 3031 (C-H Ar), 
2950 (C-H alpha), 1703 (C=O cyclic imide), 1670 (C=O amide I), 1550 
(C=C Ar), 1523 (C=O amide II).
11f-N-[o-[(Ñ-o-toluylglycyl)sulfamoyl]benzamedophthalimide: 
m.p=251–249°C, yield =80%, Rf=0.497, IR (KBr) cm−1: 3274 (NH), 
3018 (C-H Ar), 2996 (C-H alpha), 1701 (C=O cyclic imide), 1660 (C=O 
amide I), 1567 (C=C Ar), 1556 (C=O amide II).
BIOLOGICAL ACTIVITY
Anti-bacterial and anti-fungal test [21]
The test was performed according to the disk diffusion assay. The 
synthesized compounds have been studied for their antimicrobial 
activity in vitro against four tested bacteria (Staphylococcus epidermidis 
and Staphylococcus aureus as Gram-positive bacteria and Klebsiella 
pneumonia and Escherichia coli as Gram-negative bacteria) and one 
type of fungi (Candida albicans).
Scheme 1: Synthesis route for the preparation of compounds (5a-b) and (6a-f)
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The agar and Petri dishes were sterilized by autoclaving for 15 min 
at 121°C. The agar plates were surface inoculated uniformly from the 
broth culture of the tested microorganisms. The suitably spaced apart 
holes in a solidified medium were made all 6 mm in diameter, in which 
they were filled with 100 µL of prepared compounds (1 mg of the 
compound dissolved in 1 mL of DMSO solvent), and ciprofloxacin was 
used as a standard. The incubation of these plates was for 24 h at 37°C 
(Scheme 1 and 2).
RESULTS AND DISCUSSION
N-(Ñ-substituted phenylglycyl) saccharin derivatives (1a,b) as a starting 
material were prepared according to the literature method [11]. It 
reacts with sodium hydroxide to give benzoic acid derivatives (2a,b), 
benzoic acid derivatives react with absolute ethanol in the presence of 
concentrated H2SO4 to give ester derivatives (3a,b), and then it reacts 
with 80% hydrazine hydrate to give benzohydrazide derivatives (4a,b). 
The disappearance of (C=O ester) stretching band at 1715–1726 cm−1 
and the appearance of new stretching bands at 3402–3305 cm−1 and 
1631 cm−1 which are due to (NH-NH2) and (C=O amide), respectively, 
are attributed to the formation of benzohydrazide derivative (4a,b). The 
cyclization of (4a,b) with carbon disulfide in the presence of potassium 
hydroxide then added hydrazine hydrate to give the corresponding 
1,2,4-triazole compound (5a,b). IR spectrum show the absence of the 
stretching band at (1631) cm−1 for C=O amide and appearance of 
stretching band for (C=N) at 1596 cm−1 it was good evidence for the 
formation of 1,2,4- triazole derivative, 1H-NMR spectrum of compound 
Scheme 2: Synthesis route for the preparation of compounds (8a-b), (10a-f), and (11a-f)
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(5a,b) shown the following characteristic signars 1.6 (s, 3H, Ar-CH3), 
3.6 (s, 2H, NH2), 4.2 (s, 2H, NH2- CH2-C=O), 5.2 (s, 1H, CH-triazole ring), 
7.1–8.1 (m, 9H, Ar-H, NHSO2), 12.7 (s, 1H, SH). Schiff base derivatives 
(6a-f) from 1,2,4-triazole are prepared by reacting compounds (5a,b) 
with some aromatic aldehyde such as 4,4-dimethylaminobenzaldehyde, 
4-methoxybenzaldehyde, and 2,4-dimethoxy benzaldehyde in the 
presence of few drops of glacial acetic acid. IR spectrum of compounds 
(6a-f) shows the disappearance of (NH2) stretching band at 3402–3305 
cm−1 and appearance bands of (C=N) at 1602–1624 cm−1 and (N-H) 
at 3253 cm−1. N-(chloroacetyl) benzohydrazide derivatives (7a,b) 
were prepared by the reaction of compounds (4a,b) with chloroacetyl 
chloride; IR spectrum of compounds (7a,b) shown disappearance of 
(NH-NH2) overlapping with (NH) 3402–3305 cm−1 and appearance of 
1703–1610 cm−1 (C=O) and 794 cm−1 (C-Cl). 1,3-thiazole compounds 
(8a,b) were produced by the reaction of compounds (7a,b) with 
thiourea. IR spectrum of compounds (8a,b) shown the disappearance 
of stretching bands 1702–1610 cm−1 (C=O) and 794 cm−1 (C-Cl), 
and appearance of 1606–1602 cm−1 (C=N) and 3900–3200 cm−1 
(N-H-NH2); 1H-NMR spectrum of compounds (8a,b) shown: 1.6 (s, 
3H, CH3-Ar), 3.3 (s, 2H, O=C-CH2-NH), 3.7 (s, 2H, NH2), 4.1 (s, 1H, CH 
thiazolering), 7.1–7.9 (m, 9H, Ar-H, NHSO2), and 11.7 (s, 1H, O=C-
NH-NH). Schiff bases (9a-f) were obtained by condensation of (4a,b) 
with 4,4-dimethylaminobenzaldehyde, 4-methoxybenzaldehyde, 
and 2,4-dimethoxy benzaldehyde in the presence of few drops of 
glacial acetic acid. IR spectrum data of compounds (9a-f) shown 
disappearance of (NH-NH2) overlapping with (NH) 3402–3305 cm−1 
and appearance of (C=N) 1602–1523 cm−11, (C=O) 1623–1600 cm−1, the 
1H-NMR spectrum showed the following characteristic signals δ (ppm): 
Compound (9c): 1.5 (s, 3H, Ar-CH3), 3.4 (s, 3H, OCH3), 3.8 (s, 2H, O=C-
CH2-NH), 6.6 (s, 1H, CH=N), 7.1–7.9 (m, 9H, Ar-H, NHSO2), 8.8 (s, 1H, 
O=C-NH-N), compound (9d): 1.6 (s, 3H, Ar-CH3), 3.3 (s, 6H, (CH3)2N), 3.8 
(s, 2H, O=C-CH2-NH), 6.7 (s, 1H, CH=N), 7.1–7.9 (m, 9H, Ar-H, NHSO2), 
8.4 (s, 1H, O=C-NH-N). Aza-β-lactam compounds (10a-f) were prepared 
by the cycloaddition of Schiff bases (9a-f) with phenyl isocyanate via. 
(2+2) cycloaddition reaction, IR spectrum data shown disappearance 
of (C=N) 1602–1523 cm−1, (C=O) 1623–1600 cm−1 and appearance of 
1710–1701 cm−1 (C=O aza-β-lactam), 1H-NMR spectrum of compound 
(10c): 1.2 (s, 1H, NH-Ar), 1.6 (s, 3H, CH3-Ar), 3.6 (s, 3H, p-OCH3), 3.8 (s, 
3H, o-OCH3), 4.1 (s, 2H, O=C-CH2), 6.5 (s, 1H, N-CH-aza-β-lactam), 6.9–
9.5 (m, 9H, Ar-H, NHSO2), 11.1 (s, 1H, N-NH-C=O). Compound (10d): 
1.2 (s, 1H, NH-Ar), 1.6 (s, 3H, CH3-Ar), 3.4 (s, 6H, (CH3)2-N), 4.1 (s, 2H, 
O=C-CH2), 6.5 (s, 1H, N-CH-aza-β-lactam), 6.9–9.5 (m, 9H, Ar-H, NHSO2), 
11.4 (s, 1H, N-NH-C=O). Reaction (4a-b) with various acid anhydrides, 
namely succinic anhydride, maleic anhydride, and phthalic anhydride, 
in the presence of acetic acid gave the corresponding cyclicimide (11a-
f), IR spectrum of compounds (11a-f) shown disappearance of (NH-
NH2) overlapping with (NH) at 3402–3305 cm−1 and appearance of 
1797–1724 cm−1 (C=O) cyclicimide. 1H-NMR spectrum of compound 
(11c) shown: 1.6 (s, 3H, Ar-CH3), 3.2 (s, 2H, Ar-NH-CH2), 7.4–8.2 (m, 
13H, Ar-H, NHSO2), and 11.5 (s, 1H, C=O-NH-N-). The antimicrobial 
activity done on four different strains of bacteria and one type of fungi. 
The results showed that compounds (11a) and (8e) have a good activity 
against Gram-positive bacterium and no activity against Gram-negative 
bacterium, compared to standards drugs (ciprofloxacin, amoxicillin), 
while compounds (10a) and (12b) have a high activity against fungi, 
compared to standard drugs (metronidazole benzoate), and the other 
tested compounds have low to moderate activity.
Antibacterial and antifungal assay
Some of the prepared compounds were tested against two strain of 
Gram-positive bacteria such as S. aureus and S. epidermidis, two strains 
of Gram-negative bacteria such as K. pneumonia and E. coli, and one 
strain of fungi C. albicans. The agar and Petri dishes were sterilized by 
autoclaving for 15 min at 121°C. The agar plates were surface inoculated 
uniformly from the broth culture of the tested microorganisms. The 
suitably spaced apart holes in the solidified medium were made 
all 6 mm in diameter, in which were filled with 100 μl of prepared 
compounds (1 mg of the compound dissolved in 1 mL of DMSO solvent), 
ciprofloxacin, amoxicillin was used as the standard for bacterial test 
and metroniolazorbenzoate stander for fungi. The incubation of these 
plates was for 24 h at 37°C (Table 1 ana 2) [21].
CONCLUSION
5a is a most potent assemblage of Gram-positive bacterium retardants 
and 8a is a most potent assemblage of fungi retardants.
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Table 1: Antibacterial activity of compounds (8b-12f)
Compound 
number









8b 10 9 8 -
8c - 10 9 -
8e 16 10 - 8
8f 9 10 10 -
10a 10 10 9 -
11a 9 20 8 -
11b 10 9 8 -
12a 10 10 9 14
12b 9 10 9 -
12d - 10 9 -
12f 9 9 8 -
Ciprofloxacin 25 30 30 30
Amoxicillin 18 15 17 20
Table 2: Antifungal activity of compounds (7f-12b)
Compound no Zone of inhibition in (mm), 
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